Ascendis Pharma is a dynamic, global biopharma company headquartered in Copenhagen, Denmark. We are publicly traded, following an initial public offering in 2015 (Nasdaq: ASND). We have research facilities in Germany, and offices across Europe and the United States. Today, we’re advancing programs in Endocrinology Rare Disease and Oncology. In addition, we collaborate on the development of TransCon-based product candidates in other therapeutic areas and markets.
Here at Ascendis, we pride ourselves on exceptional science, visionary leadership, and skilled and passionate colleagues.
Guided by our core values of Patients, Science, and Passion, we use our TransCon® drug development platform to fulfill our mission of developing new and potentially best-in-class therapies to address unmet medical needs.
Our culture fosters a place where skilled, adaptable, and highly resourceful professionals can truly make their mark. We offer a dynamic workplace for employees to...